Drug Profile
Anti-Tac(Fv)-PE38KDEL conjugate
Alternative Names: Anti-Tac(Fv)-PE38KDEL; rDNA anti-Tac immunotoxinLatest Information Update: 01 Sep 1998
Price :
$50
*
At a glance
- Originator PDL BioPharma
- Class Drug conjugates; Immunotoxins
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Graft-versus-host disease
Most Recent Events
- 01 Sep 1998 No-Development-Reported for Graft-versus-host disease in USA (Unknown route)
- 23 Aug 1996 New profile
- 23 Aug 1996 Preclinical development for Graft-versus-host disease in USA (Unknown route)